ClinVar Miner

Submissions for variant NM_182961.4(SYNE1):c.24952C>T (p.Leu8318Phe)

gnomAD frequency: 0.00570  dbSNP: rs141716975
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000174640 SCV000225972 benign not specified 2015-01-07 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000174640 SCV000315145 likely benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000987801 SCV000460899 likely benign Autosomal recessive ataxia, Beauce type 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Illumina Laboratory Services, Illumina RCV000321230 SCV000460900 benign Emery-Dreifuss muscular dystrophy 4, autosomal dominant 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000710252 SCV000514843 likely benign not provided 2021-04-16 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge
Athena Diagnostics Inc RCV000710252 SCV000615645 benign not provided 2018-01-16 criteria provided, single submitter clinical testing
Invitae RCV001081859 SCV000649144 benign Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant 2024-01-28 criteria provided, single submitter clinical testing
Mendelics RCV000987801 SCV001137257 likely benign Autosomal recessive ataxia, Beauce type 2019-05-28 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000710252 SCV001154910 likely benign not provided 2024-02-01 criteria provided, single submitter clinical testing SYNE1: BP4, BS2
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000710252 SCV001158147 likely benign not provided 2023-10-26 criteria provided, single submitter clinical testing
Ambry Genetics RCV002516637 SCV003692368 uncertain significance Inborn genetic diseases 2021-10-21 criteria provided, single submitter clinical testing The c.24739C>T (p.L8247F) alteration is located in exon 136 (coding exon 135) of the SYNE1 gene. This alteration results from a C to T substitution at nucleotide position 24739, causing the leucine (L) at amino acid position 8247 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000710252 SCV001799690 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000710252 SCV001956131 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000710252 SCV001976113 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.